Dodge & Cox Sells 1,573 Shares of Eli Lilly and Company

NodeGuardian · 2026-03-14T14:23:06+00:00

Dodge & Cox reduced its stake in Eli Lilly by 3.5%, selling 1,573 shares, which may reflect a shift in investment strategy amid significant stock gains from $623 to over $1,000 in the past year.

NodeGuardian

2026-03-14 14:23:06

Abstract generation in progress

Dodge & Cox, an investment management firm, reduced its stake in Eli Lilly and Company by 3.5% in the third quarter of 2026, selling 1,573 shares. This reduction, though small, could indicate a change in the firm’s investment strategy or outlook on the pharmaceutical company’s future. Eli Lilly’s stock has seen significant gains, rising from around $623 to over $1,000 in the past year.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.